Loading...
End-of-life palliative care patients suffering respiratory distress are challenging to treat. Most cases have a declared “do not intubate” status, and noninvasive positive pressure ventilation is uncomfortable or intolerable for many.
To determine the utility of oxygen by high-flow nasal cannula (HFNC), researchers in Thailand randomized adult palliative care patients who presented to an emergency department with respiratory failure to receive HFNC or conventional oxygen therapy (regular nasal cannula or nonrebreather mask). Each patient was assigned to one therapy for 60 minutes, then crossed over to the alternate therapy. Saturation goals were 95%. HFNC delivery was started at 35 L/minute and titrated up to 60 L/minute as needed. The prima…